FDA 调查了 13 例与两批 ByHeart 婴儿配方奶粉有关的婴儿肉毒杆菌中毒病例，促使召回。 FDA investigates 13 infant botulism cases linked to two lots of ByHeart infant formula, prompting a recall.

美国食品和药物管理局正在调查10个州的13例婴儿肉毒症病例,与ByHeart Inc.的两批全营养婴儿配方奶粉有关,促使206VABP/251261P2和206VABP/251131P2的批量被召回. The FDA is investigating 13 infant botulism cases across 10 states linked to two lots of Whole Nutrition Infant Formula by ByHeart Inc., prompting a recall of lots 206VABP/251261P2 and 206VABP/251131P2. 所有受到影响的婴儿都住院治疗,但没有死亡。 All affected infants were hospitalized but no deaths occurred. 该公式可在网上和商店获得,占全国销售的1%左右。 The formula, available online and in stores, made up about 1% of national sales. 建议家长检查批数、丢弃或归还产品、清洁污染表面,如果婴儿出现喂养不良、软弱或呼吸困难等症状,应寻求医疗护理。 Parents are advised to check lot numbers, discard or return the product, clean contaminated surfaces, and seek medical care if infants show symptoms like poor feeding, weakness, or breathing difficulties. 美国食品和药物管理局正在调查污染源以及其他产品是否受到影响. The FDA is probing contamination sources and whether other products are affected.